Browse Tag

BSI

Croda and Botanical Solution Inc. (BSI) join forces in a collaborative endeavor to expedite the manufacturing of QS-21, a sustainable vaccine adjuvant.

May 24, 2023

Croda and Botanical Solution Inc. (BSI) partner to fast-track sustainable vaccine adjuvant QS-21 production

Davis, California – Croda Pharma and BSI announced that they have entered into a strategic collaboration agreement to support the sustainable sourcing of pharmaceutical grade adjuvant QS-21, a potent component of adjuvant systems. QS-21 is used in several innovative vaccines against diseases such as

March 10, 2021

Syngenta and Botanical Solution Inc. (BSI) team up for a new botanical-based biofungicde rollout !

Davis, CA: Botanical Solution Inc. (BSI) and Syngenta, two companies which are closely aligned

December 24, 2020

Botanical Solution Inc. (BSI) Secures $3.3 Million in Funding with Second Round Planned for Spring 2021

Davis, CA: Botanical Solution Inc. (BSI), innovator of sustainable, highly consistent and cost effective

Pharmaceutical News

Botanical Solution Inc. (BSI) Secures $6.1 Million in Series A First Closing

January 17, 2022

January 17, 2022 (Davis, CA) – Botanical Solution Inc. (BSI), innovator of sustainable, consistent, and cost-effective Advanced Botanical Materials for

Pharmaceutical News

QS-21, the ‘Gold Standard’ of immune system activators used in Covid-19 and other vaccines to be presented by CEO Gaston Salinas at BIO CEO & Investor Conference

February 18, 2021

A novel approach for ensuring the virtually unlimited production of QS-21, the ‘Gold Standard’ adjuvant for improving vaccine efficacy, will

Go toTop